0001209191-18-007238.txt : 20180202 0001209191-18-007238.hdr.sgml : 20180202 20180202195447 ACCESSION NUMBER: 0001209191-18-007238 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180131 FILED AS OF DATE: 20180202 DATE AS OF CHANGE: 20180202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reiner Deborah M CENTRAL INDEX KEY: 0001720832 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11239 FILM NUMBER: 18572534 MAIL ADDRESS: STREET 1: ONE PARK PLAZA CITY: NASHVILLE STATE: TN ZIP: 37048 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HCA Healthcare, Inc. CENTRAL INDEX KEY: 0000860730 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 273865930 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PARK PLZ CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6153449551 MAIL ADDRESS: STREET 1: ONE PARK PLAZA CITY: NASHVILLE STATE: TN ZIP: 37203 FORMER COMPANY: FORMER CONFORMED NAME: HCA Holdings, Inc. DATE OF NAME CHANGE: 20101126 FORMER COMPANY: FORMER CONFORMED NAME: HCA INC/TN DATE OF NAME CHANGE: 20010627 FORMER COMPANY: FORMER CONFORMED NAME: HCA THE HEALTHCARE CO DATE OF NAME CHANGE: 20010419 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-31 0 0000860730 HCA Healthcare, Inc. HCA 0001720832 Reiner Deborah M ONE PARK PLAZA NASHVILLE TN 37203 0 1 0 0 SVP - Mktg. & Communications Common Stock 2018-01-31 4 M 0 5000 22.95 A 7020 D Common Stock 2018-01-31 4 M 0 6525 47.97 A 13545 D Common Stock 2018-01-31 4 M 0 3000 68.96 A 16545 D Common Stock 2018-01-31 4 M 0 1495 69.58 A 18040 D Common Stock 2018-01-31 4 S 0 2020 102.00 D 16020 D Common Stock 2018-01-31 4 F 0 9475 101.16 D 6545 D Common Stock 2018-02-02 4 S 0 6545 101.54 D 0 D Stock Appreciation Right 22.95 2018-01-31 4 M 0 2500 0.00 D 2022-02-08 Common Stock 2500 0 D Stock Appreciation Right 22.95 2018-01-31 4 M 0 2500 0.00 D 2022-02-08 Common Stock 2500 0 D Stock Appreciation Right 47.97 2018-01-31 4 M 0 3150 0.00 D 2024-02-05 Common Stock 3150 0 D Stock Appreciation Right 47.97 2018-01-31 4 M 0 3375 0.00 D 2024-02-05 Common Stock 3375 1125 D Stock Appreciation Right 68.96 2018-01-31 4 M 0 3000 0.00 D 2025-02-04 Common Stock 3000 3000 D Stock Appreciation Right 69.58 2018-01-31 4 M 0 1495 0.00 D 2026-01-29 Common Stock 1495 4485 D Stock Appreciation Right 101.16 2018-01-31 4 A 0 13730 0.00 A 2019-01-31 2028-01-31 Common Stock 13730 13730 D The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. The stock appreciation rights vested at the end of fiscal years 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015. The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016. The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017. The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. /s/ Kevin A. Ball, Attorney-in-Fact 2018-02-02 EX-24.4_766114 2 poa.txt POA DOCUMENT POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints John M. Franck II, Natalie Harrison Cline and Kevin A. Ball as the undersigned's true and lawful attorneys-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of the undersigned to: (1) prepare, execute, acknowledge, deliver and file a Form ID (including any amendments or authentications thereto) with respect to obtaining EDGAR codes, with the U.S. Securities and Exchange Commission; (2) prepare, execute, acknowledge, deliver and file Forms 3, 4 and 5 (including any amendments thereto) with respect to the securities of HCA Healthcare, Inc., a Delaware corporation (the "Company"), with the U.S. Securities and Exchange Commission, any national securities exchanges and the Company, as considered necessary or advisable under Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as amended from time to time (the "Exchange Act"); (3) seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information; and (4) perform any and all other acts which in the discretion of such attorneys-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing. The undersigned acknowledges that: (1) this Power of Attorney authorizes, but does not require, such attorneys-in-fact to act in their discretion on information provided to such attorneys-in-fact without independent verification of such information; (2) any documents prepared and/or executed by such attorneys-in-fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable; (3) neither the Company nor such attorneys-in-fact assumes (i) any liability for the undersigned's responsibility to comply with the requirements of the Exchange Act, (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and (4) this Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act. The undersigned hereby gives and grants the foregoing attorneys-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, with full power of substitution and revocation, hereby ratifying all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, of, for and on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this Power of Attorney. This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to such attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 20th day of October 2017. /s/ Deborah M. Reiner Print Name: Deborah M. Reiner